Download PDF
Fortschr Neurol Psychiatr 2005; 73(8): 438-450
DOI: 10.1055/s-2004-830303
Originalarbeit
© Georg Thieme Verlag Stuttgart · New York

Exekutive Kontrollfunktionen und Neuropsychiatrische Erkrankungen - Perspektiven für Forschung und Klinik

Executive Control Functions and Neuropsychiatric Disorders - Perspectives for Research und Clinical PracticeS.  Kaiser1 , C.  Mundt1 , M.  Weisbrod1
  • 1Psychiatrische Universitätsklinik Heidelberg (Ärztlicher Direktor: Prof. Dr. med. Ch. Mundt)
Further Information

Publication History

Publication Date:
11 May 2005 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Exekutive Kontrollfunktionen sind höhere kognitive Funktionen für komplexes zielgerichtetes Verhalten in Situationen, in denen Routinemechanismen nicht vorhanden oder nicht adäquat sind. Klinisch äußern sich exekutive Störungen außer in kognitiven Funktionen auch in Sozialverhalten und Antrieb. Exekutive Kontrollfunktionen basieren auf intakten Netzwerken zwischen präfrontalem Kortex und subkortikalen Strukturen, die in ihrer Funktion durch monoaminerge Neurotransmitter moduliert werden. Defizite exekutiver Kontrolle sind bei verschiedenen neuropsychiatrischen Erkrankungen beschrieben worden. Wir geben eine Übersicht über die Befunde mit einem Fokus auf extrapyramidale Bewegungsstörungen, Schizophrenie und affektive Störungen. Ein Schwerpunkt liegt dabei auf Gemeinsamkeiten zwischen diesen Erkrankungen hinsichtlich der Pathophysiologie fronto-subkortikaler Netzwerke. Aufgrund dieser Gemeinsamkeiten können Grundlinien pharmakologischer und rehabilitativer Strategien nosologieübergreifend auf die Behandlung exekutiver Defizite bei verschiedenen neuropsychiatrischen Krankheitsbildern angewendet werden. Wegen der hohen prognostischen Relevanz exekutiver Defizite sind kontrollierte Studien dieser Therapieverfahren dringend erforderlich.

Abstract

Executive control functions are higher cognitive functions for complex goal-oriented behavior in situations where routine mechanisms are not available or inappropriate. In clinical practice executive dysfunction presents with deficits in cognitive function as well as social behavior and drive. Executive control functions rely on intact networks involving prefrontal cortex and subcortical structures, which can be modulated by monoaminergic neurotransmitters. Deficits of executive control have been described in a variety of neuropsychiatric disorders. We present a review of the findings with a focus on movement disorders, schizophrenia and affective disorders. We emphasize similarities between these disorders regarding the pathophysiology of fronto-subcortical networks. Based on these similarities, principles of pharmacological and rehabilitative strategies can be applied to the treatment of executive deficits in a variety of neuropsychiatric disorders without being specific for one disease. Since executive dysfunction is highly relevant to prognosis, controlled trials of these treatments are urgently needed.

Literatur

  • 1 Schneider W, Shiffrin R M. Controlled and automatic human information processing I: Detection, search and attention.  Psychol Rev. 1977;  84 1-66
    CrossrefPubMedGoogle Scholar
  • 2 Shiffrin R M, Schneider W. Controlled and automatic human information processing: II. Perceptual learning, automatic attending and a general theory.  Psychol Rev. 1977;  84 127-190
    CrossrefPubMedGoogle Scholar
  • 3 Hasher L, Zacks R T. Automatic and effortful processes in memory.  J Exp Psychol Gen. 1979;  108 356-389
    PubMedGoogle Scholar
  • 4 Norman D A, Shallice T. Attention to action: Willed and automatic control of behavior. In: Davidson R, Schwartz G, Shapiro D (Hrsg). Consciousness and self-regulation. New York: Plenum Press 1986: 1-18
    Google Scholar
  • 5 Stuss D T, Benson D F. The Frontal Lobes. New York: Raven 1986
    Google Scholar
  • 6 Robbins T W. Dissociating executive functions of the prefrontal cortex.  Philos Trans R Soc Lond B Biol Sci. 1996;  351 (1346) 1463-1470
    PubMedGoogle Scholar
  • 7 Stuss D T, Shallice T, Alexander M P, Picton T W. A multidisciplinary approach to anterior attentional functions.  Ann N Y Acad Sci. 1995;  769 191-211
    CrossrefPubMedGoogle Scholar
  • 8 Shallice T, Burgess P. The domain of supervisory processes and temporal organization of behaviour.  Philos Trans R Soc Lond B Biol Sci. 1996;  351 (1346) 1405-1411; discussion 1411 - 1412
    PubMedGoogle Scholar
  • 9 Royall D R, Lauterbach E C, Cummings J L, Reeve A, Rummans T A, Kaufer D I, LaFrance Jr W C, Coffey C E. Executive control function: a review of its promise and challenges for clinical research. A report from the Committee on Research of the American Neuropsychiatric Association.  J Neuropsychiatry Clin Neurosci. 2002;  14 (4) 377-405
    CrossrefPubMedGoogle Scholar
  • 10 Alexander G E, DeLong M R, Strick P L. Parallel organization of functionally segregated circuits linking basal ganglia and cortex.  Annu Rev Neurosci. 1986;  9 357-381
    CrossrefPubMedGoogle Scholar
  • 11 Goldman-Rakic P S. Circuitry of primate prefrontal cortex and regulation of behavior by representational knowledge. In: Plum F, Mountcastle V (Hrsg). Handbook of Physiology. Bethesda: American Physiological Society 1987: 373-417
    Google Scholar
  • 12 Mega M S, Cummings J L. Frontal-subcortical circuits and neuropsychiatric disorders.  J Neuropsychiatry Clin Neurosci. 1994;  6 (4) 358-370
    PubMedGoogle Scholar
  • 13 Alexander G E, Crutcher M D. Functional architecture of basal ganglia circuits: neural substrates of parallel processing.  Trends Neurosci. 1990;  13 (7) 266-271
    CrossrefPubMedGoogle Scholar
  • 14 Graybiel A M. The basal ganglia.  Curr Biol. 2000;  10 (14) R509-511
    CrossrefPubMedGoogle Scholar
  • 15 Arnsten A F. Catecholamine regulation of the prefrontal cortex.  J Psychopharmacol. 1997;  11 (2) 151-162
    PubMedGoogle Scholar
  • 16 Tekin S, Cummings J L. Frontal-subcortical neuronal circuits and clinical neuropsychiatry: an update.  J Psychosom Res. 2002;  53 (2) 647-654
    CrossrefPubMedGoogle Scholar
  • 17 Berman K F, Ostrem J L, Randolph C, Gold J, Goldberg T E, Coppola R, Carson R E, Herscovitch P, Weinberger D R. Physiological activation of a cortical network during performance of the Wisconsin Card Sorting Test: a positron emission tomography study.  Neuropsychologia. 1995;  33 (8) 1027-1046
    CrossrefPubMedGoogle Scholar
  • 18 D'Esposito M, Detre J A, Alsop D C, Shin R K, Atlas S, Grossman M. The neural basis of the central executive system of working memory.  Nature. 1995;  378 (6554) 279-281
    CrossrefPubMedGoogle Scholar
  • 19 Bechara A, Damasio H, Damasio A R. Emotion, decision making and the orbitofrontal cortex.  Cereb Cortex. 2000;  10 (3) 295-307
    CrossrefPubMedGoogle Scholar
  • 20 Drewe E A. Go-Nogo learning after frontal lobe lesions in humans.  Cortex. 1975;  11 8-16
    PubMedGoogle Scholar
  • 21 Starkstein S E, Robinson R G. Mechanism of disinhibition after brain lesions.  J Nerv Ment Dis. 1997;  185 (2) 108-114
    CrossrefPubMedGoogle Scholar
  • 22 Posner M I, DiGirolamo G. Executive attention: Conflict, target detection and cognitive control. In: Parasuraman R (Hrsg). The attentive brain. Cambridge: MIT Press 1998: 401-423
    Google Scholar
  • 23 Cohen R A, Kaplan R F, Moser D J, Jenkins M A, Wilkinson H. Impairments of attention after cingulotomy.  Neurology. 1999;  53 (4) 819-824
    PubMedGoogle Scholar
  • 24 Barch D M, Carter C S, Hachten P C, Usher M, Cohen J D. The „benefits” of distractibility: mechanisms underlying increased Stroop effects in schizophrenia.  Schizophr Bull. 1999;  25 (4) 749-762
    PubMedGoogle Scholar
  • 25 Swerdlow N R, Koob G F. Dopamine, schizophrenia, mania and depression: Toward a unified hypothesis of cortico-striato-pallido-thalamic function.  Behav Brain Sci. 1987;  10 197-245
    PubMedGoogle Scholar
  • 26 Heimer L. A new anatomical framework for neuropsychiatric disorders and drug abuse.  Am J Psychiatry. 2003;  160 (10) 1726-1739
    CrossrefPubMedGoogle Scholar
  • 27 Ovsiew F, Bylsma F W. The three cognitive examinations.  Semin Clin Neuropsychiatry. 2002;  7 (1) 54-64
    CrossrefPubMedGoogle Scholar
  • 28 Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB: a Frontal Assessment Battery at bedside.  Neurology. 2000;  55 (11) 1621-1626
    CrossrefPubMedGoogle Scholar
  • 29 Ring H A, Serra-Mestres J. Neuropsychiatry of the basal ganglia.  J Neurol Neurosurg Psychiatry. 2002;  72 (1) 12-21
    CrossrefPubMedGoogle Scholar
  • 30 Pirozzolo F J, Hansch E C, Mortimer J A, Webster D D, Kuskowski M A. Dementia in Parkinson disease: a neuropsychological analysis.  Brain Cogn. 1982;  1 (1) 71-83
    PubMedGoogle Scholar
  • 31 Hietanen M, Teravainen H. Cognitive performance in early Parkinson's disease.  Acta Neurol Scand. 1986;  73 (2) 151-159
    PubMedGoogle Scholar
  • 32 Lees A J, Smith E. Cognitive deficits in the early stages of Parkinson's disease.  Brain. 1983;  106 (Pt 2) 257-270
    PubMedGoogle Scholar
  • 33 Kaasinen V, Rinne J O. Functional imaging studies of dopamine system and cognition in normal aging and Parkinson's disease.  Neurosci Biobehav Rev. 2002;  26 (7) 785-793
    CrossrefPubMedGoogle Scholar
  • 34 Brown R G, Marsden C D. How common is dementia in Parkinson's disease?.  Lancet. 1984;  2 (8414) 1262-1265
    PubMedGoogle Scholar
  • 35 Mortimer J A, Pirozzolo F J, Hansch E C, Webster D D. Relationship of motor symptoms to intellectual deficits in Parkinson disease.  Neurology. 1982;  32 (2) 133-137
    PubMedGoogle Scholar
  • 36 Cooper J A, Sagar H J, Jordan N, Harvey N S, Sullivan E V. Cognitive impairment in early, untreated Parkinson's disease and its relationship to motor disability.  Brain. 1991;  114 ( Pt 5) 2095-2122
    CrossrefPubMedGoogle Scholar
  • 37 Dubois B, Pillon B. Cognitive deficits in Parkinson's disease.  J Neurol. 1997;  244 (1) 2-8
    PubMedGoogle Scholar
  • 38 Muller U, Wachter T, Barthel H, Reuter M, Cramon D Y von. Striatal [123I]beta-CIT SPECT and prefrontal cognitive functions in Parkinson's disease.  J Neural Transm. 2000;  107 (3) 303-319
    CrossrefPubMedGoogle Scholar
  • 39 Cooper J A, Sagar H J, Doherty S M, Jordan N, Tidswell P, Sullivan E V. Different effects of dopaminergic and anticholinergic therapies on cognitive and motor function in Parkinson's disease. A follow-up study of untreated patients.  Brain. 1992;  115 ( Pt 6) 1701-1725
    CrossrefPubMedGoogle Scholar
  • 40 Lange K W, Robbins T W, Marsden C D, James M, Owen A M, Paul G M. L-dopa withdrawal in Parkinson's disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction.  Psychopharmacology (Berl). 1992;  107 (2 - 3) 394-404
    PubMedGoogle Scholar
  • 41 Hietanen M, Teravainen H. Dementia and treatment with L-dopa in Parkinson's disease.  Mov Disord. 1988;  3 (3) 263-270
    CrossrefPubMedGoogle Scholar
  • 42 Robbins T W, James M, Owen A M, Lange K W, Lees A J, Leigh P N, Marsden C D, Quinn N P, Summers B A. Cognitive deficits in progressive supranuclear palsy, Parkinson's disease, and multiple system atrophy in tests sensitive to frontal lobe dysfunction.  J Neurol Neurosurg Psychiatry. 1994;  57 (1) 79-88
    CrossrefPubMedGoogle Scholar
  • 43 Blin J, Baron J C, Dubois B, Pillon B, Cambon H, Cambier J, Agid Y. Positron emission tomography study in progressive supranuclear palsy. Brain hypometabolic pattern and clinicometabolic correlations.  Arch Neurol. 1990;  47 (7) 747-752
    CrossrefPubMedGoogle Scholar
  • 44 Lange K W, Sahakian B J, Quinn N P, Marsden C D, Robbins T W. Comparison of executive and visuospatial memory function in Huntington's disease and dementia of Alzheimer type matched for degree of dementia.  J Neurol Neurosurg Psychiatry. 1995;  58 (5) 598-606
    PubMedGoogle Scholar
  • 45 Lawrence A D, Sahakian B J, Hodges J R, Rosser A E, Lange K W, Robbins T W. Executive and mnemonic functions in early Huntington's disease.  Brain. 1996;  119 (Pt 5) 1633-1645
    PubMedGoogle Scholar
  • 46 Backman L, Robins-Wahlin T B, Lundin A, Ginovart N, Farde L. Cognitive deficits in Huntington's disease are predicted by dopaminergic PET markers and brain volumes.  Brain. 1997;  120 (Pt 12) 2207-2217
    CrossrefPubMedGoogle Scholar
  • 47 Morice R, Delahunty A. Frontal/executive impairments in schizophrenia.  Schizophr Bull. 1996;  22 (1) 125-137
    PubMedGoogle Scholar
  • 48 Heinrichs R W, Awad A G. Neurocognitive subtypes of chronic schizophrenia.  Schizophr Res. 1993;  9 (1) 49-58
    CrossrefPubMedGoogle Scholar
  • 49 Velligan D I, Bow-Thomas C C. Executive function in schizophrenia.  Semin Clin Neuropsychiatry. 1999;  4 (1) 24-33
    PubMedGoogle Scholar
  • 50 Evans J J, Chua S E, McKenna P J, Wilson B A. Assessment of the dysexecutive syndrome in schizophrenia.  Psychol Med. 1997;  27 (3) 635-646
    CrossrefPubMedGoogle Scholar
  • 51 Franke P, Maier W, Hain C, Klingler T. Wisconsin Card Sorting Test: an indicator of vulnerability to schizophrenia?.  Schizophr Res. 1992;  6 (3) 243-249
    CrossrefPubMedGoogle Scholar
  • 52 Cannon T D, Huttunen M O, Lonnqvist J, Tuulio-Henriksson A, Pirkola T, Glahn D, Finkelstein J, Hietanen M, Kaprio J, Koskenvuo M. The inheritance of neuropsychological dysfunction in twins discordant for schizophrenia.  Am J Hum Genet. 2000;  67 (2) 369-382
    CrossrefPubMedGoogle Scholar
  • 53 Weinberger D R, Egan M F, Bertolino A, Callicott J H, Mattay V S, Lipska B K, Berman K F, Goldberg T E. Prefrontal neurons and the genetics of schizophrenia.  Biol Psychiatry. 2001;  50 (11) 825-844
    CrossrefPubMedGoogle Scholar
  • 54 Pantelis C, Maruff P. The cognitive neuropsychiatric approach to investigating the neurobiology of schizophrenia and other disorders.  J Psychosom Res. 2002;  53 (2) 655-664
    CrossrefPubMedGoogle Scholar
  • 55 Kolb B, Whishaw I Q. Performance of schizophrenic patients on tests sensitive to left or right frontal, temporal, or parietal function in neurological patients.  J Nerv Ment Dis. 1983;  171 (7) 435-443
    PubMedGoogle Scholar
  • 56 Morrison-Stewart S L, Williamson P C, Corning W C, Kutcher S P, Snow W G, Merskey H. Frontal and non-frontal lobe neuropsychological test performance and clinical symptomatology in schizophrenia.  Psychol Med. 1992;  22 (2) 353-359
    PubMedGoogle Scholar
  • 57 Morris R G, Rushe T, Woodruffe P W, Murray R M. Problem solving in schizophrenia: a specific deficit in planning ability.  Schizophr Res. 1995;  14 (3) 235-246
    CrossrefPubMedGoogle Scholar
  • 58 Park S, Holzman P S. Schizophrenics show spatial working memory deficits.  Arch Gen Psychiatry. 1992;  49 (12) 975-982
    PubMedGoogle Scholar
  • 59 Wexler B E, Stevens A A, Bowers A A, Sernyak M J, Goldman-Rakic P S. Word and tone working memory deficits in schizophrenia.  Arch Gen Psychiatry. 1998;  55 (12) 1093-1096
    PubMedGoogle Scholar
  • 60 Pearlson G D, Marsh L. Structural brain imaging in schizophrenia: a selective review.  Biol Psychiatry. 1999;  46 (5) 627-649
    CrossrefPubMedGoogle Scholar
  • 61 Falkai P, Vogeley K, Maier W. Hirnstrukturelle Veränderungen bei Patienten mit schizophrenen Psychosen - Von der fokalen Pathologie zur Netzwerkstörung.  Nervenarzt. 2001;  72 (5) 331-341
    CrossrefPubMedGoogle Scholar
  • 62 Weinberger D R, Berman K F, Zec R F. Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence.  Arch Gen Psychiatry. 1986;  43 (2) 114-124
    PubMedGoogle Scholar
  • 63 Carter C S, Perlstein W, Ganguli R, Brar J, Mintun M, Cohen J D. Functional hypofrontality and working memory dysfunction in schizophrenia.  Am J Psychiatry. 1998;  155 (9) 1285-1287
    PubMedGoogle Scholar
  • 64 Curtis V A, Bullmore E T, Brammer M J, Wright I C, Williams S C, Morris R G, Sharma T S, Murray R M, McGuire P K. Attenuated frontal activation during a verbal fluency task in patients with schizophrenia.  Am J Psychiatry. 1998;  155 (8) 1056-1063
    PubMedGoogle Scholar
  • 65 Orzack M H, Kornetsky C. Attention dysfunction in chronic schizophrenia.  Arch Gen Psychiatry. 1966;  14 323-326
    PubMedGoogle Scholar
  • 66 Hepp H H, Maier S, Hermle L, Spitzer M. The Stroop effect in schizophrenic patients.  Schizophr Res. 1996;  22 (3) 187-195
    CrossrefPubMedGoogle Scholar
  • 67 Wykes T, Reeder C, Corner J. The prevalence and stability of an executive processing deficit, response inhibition, in people with chronic schizophrenia.  Schizophr Res. 2000;  46 (2 - 3) 241-253
    CrossrefPubMedGoogle Scholar
  • 68 Sanfilipo M, Lafargue T, Rusinek H, Arena L, Loneragan C, Lautin A, Feiner D, Rotrosen J, Wolkin A. Volumetric measure of the frontal and temporal lobe regions in schizophrenia: relationship to negative symptoms.  Arch Gen Psychiatry. 2000;  57 (5) 471-480
    PubMedGoogle Scholar
  • 69 Wilder K E, Weinberger D R, Goldberg T E. Operant conditioning and the orbitofrontal cortex in schizophrenic patients: unexpected evidence for intact functioning.  Schizophr Res. 1998;  30 (2) 169-174
    CrossrefPubMedGoogle Scholar
  • 70 Hutton S B, Murphy F C, Joyce E M, Rogers R D, Cuthbert I, Barnes T R, McKenna P J, Sahakian B J, Robbins T W. Decision making deficits in patients with first-episode and chronic schizophrenia.  Schizophr Res. 2002;  55 (3) 249-257
    CrossrefPubMedGoogle Scholar
  • 71 Carter C S, Mintun M, Nichols T, Cohen J D. Anterior cingulate gyrus dysfunction and selective attention deficits in schizophrenia: [15O]H2O PET study during single-trial Stroop task performance.  Am J Psychiatry. 1997;  154 (12) 1670-1675
    PubMedGoogle Scholar
  • 72 Rubia K, Russell T, Bullmore E T, Soni W, Brammer M J, Simmons A, Taylor E, Andrew C, Giampietro V, Sharma T. An fMRI study of reduced left prefrontal activation in schizophrenia during normal inhibitory function.  Schizophr Res. 2001;  52 (1 - 2) 47-55
    CrossrefPubMedGoogle Scholar
  • 73 Fallgatter A J, Muller T J. Electrophysiological signs of reduced prefrontal response control in schizophrenic patients.  Psychiatry Res. 2001;  107 (1) 19-28
    PubMedGoogle Scholar
  • 74 Weisbrod M, Kiefer M, Marzinzik F, Spitzer M. Executive control is disturbed in schizophrenia: evidence from event- related potentials in a Go/NoGo task.  Biol Psychiatry. 2000;  47 (1) 51-60
    CrossrefPubMedGoogle Scholar
  • 75 Hoff A L, Riordan H, O'Donnell D W, Morris L, DeLisi L E. Neuropsychological functioning of first-episode schizophreniform patients.  Am J Psychiatry. 1992;  149 (7) 898-903
    PubMedGoogle Scholar
  • 76 Hutton S B, Puri B K, Duncan L J, Robbins T W, Barnes T R, Joyce E M. Executive function in first-episode schizophrenia.  Psychol Med. 1998;  28 (2) 463-473
    CrossrefPubMedGoogle Scholar
  • 77 Rund B R. A review of longitudinal studies of cognitive functions in schizophrenia patients.  Schizophr Bull. 1998;  24 (3) 425-435
    PubMedGoogle Scholar
  • 78 Medalia A, Gold J M, Merriam A. The effects of neuroleptics on neuropsychological test results of schizophrenics.  Archives of Clinical Neuropsychology. 1988;  3 249-271
    CrossrefPubMedGoogle Scholar
  • 79 Verdoux H, Magnin E, Bourgeois M. Neuroleptic effects on neuropsychological test performance in schizophrenia.  Schizophr Res. 1995;  14 (2) 133-139
    CrossrefPubMedGoogle Scholar
  • 80 Keefe R S, Silva S G, Perkins D O, Lieberman J A. The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis.  Schizophr Bull. 1999;  25 (2) 201-222
    PubMedGoogle Scholar
  • 81 Nieuwenstein M R, Aleman A, de Haan E H. Relationship between symptom dimensions and neurocognitive functioning in schizophrenia: a meta-analysis of WCST and CPT studies. Wisconsin Card Sorting-Test. Continuous Performance-Test.  J Psychiatr Res. 2001;  35 (2) 119-125
    CrossrefPubMedGoogle Scholar
  • 82 Hughes C, Kumari V, Soni W, Das M, Binneman B, Drozd S, O'Neil S, Mathew V, Sharma T. Longitudinal study of symptoms and cognitive function in chronic schizophrenia.  Schizophr Res. 2002;  59 (2 - 3) 137-146
    PubMedGoogle Scholar
  • 83 Robbins T W. The case of frontostriatal dysfunction in schizophrenia.  Schizophr Bull. 1990;  16 (3) 391-402
    PubMedGoogle Scholar
  • 84 Buchanan R W, Strauss M E, Kirkpatrick B, Holstein C, Breier A, Carpenter Jr W T. Neuropsychological impairments in deficit vs nondeficit forms of schizophrenia.  Arch Gen Psychiatry. 1994;  51 (10) 804-811
    PubMedGoogle Scholar
  • 85 Moore H, West A R, Grace A A. The regulation of forebrain dopamine transmission: relevance to the pathophysiology and psychopathology of schizophrenia.  Biol Psychiatry. 1999;  46 (1) 40-55
    CrossrefPubMedGoogle Scholar
  • 86 Abi-Dargham A, Mawlawi O, Lombardo I, Gil R, Martinez D, Huang Y, Hwang D R, Keilp J, Kochan L, Heertum R van, Gorman J M, Laruelle M. Prefrontal dopamine D1-receptors and working memory in schizophrenia.  J Neurosci. 2002;  22 (9) 3708-3719
    PubMedGoogle Scholar
  • 87 Friston K J. The disconnection hypothesis.  Schizophr Res. 1998;  30 (2) 115-125
    CrossrefPubMedGoogle Scholar
  • 88 Pantelis C, Barnes T R, Nelson H E, Tanner S, Weatherley L, Owen A M, Robbins T W. Frontal-striatal cognitive deficits in patients with chronic schizophrenia.  Brain. 1997;  120 ( Pt 10) 1823-1843
    CrossrefPubMedGoogle Scholar
  • 89 Jaeger J, Douglas E. Neuropsychiatric rehabilitation for persistent mental illness.  Psychiatr Q. 1992;  63 (1) 71-94
    CrossrefPubMedGoogle Scholar
  • 90 Green M F. What are the functional consequences of neurocognitive deficits in schizophrenia?.  Am J Psychiatry. 1996;  153 (3) 321-330
    CrossrefPubMedGoogle Scholar
  • 91 Velligan D I, Mahurin R K, Diamond P L, Hazleton B C, Eckert S L, Miller A L. The functional significance of symptomatology and cognitive function in schizophrenia.  Schizophr Res. 1997;  25 (1) 21-31
    CrossrefPubMedGoogle Scholar
  • 92 Breier A, Schreiber J L, Dyer J, Pickar D. National Institute of Mental Health longitudinal study of chronic schizophrenia. Prognosis and predictors of outcome.  Arch Gen Psychiatry. 1991;  48 (3) 239-246
    PubMedGoogle Scholar
  • 93 Green M F, Nuechterlein K H. Should schizophrenia be treated as a neurocognitive disorder?.  Schizophr Bull. 1999;  25 (2) 309-319
    CrossrefPubMedGoogle Scholar
  • 94 Chowdhury R, Ferrier I N, Thompson J M. Cognitive dysfunction in bipolar disorder.  Curr Opin Psychiatry. 2003;  16 7-12
    CrossrefPubMedGoogle Scholar
  • 95 Austin M P, Mitchell P, Goodwin G M. Cognitive deficits in depression: possible implications for functional neuropathology.  Br J Psychiatry. 2001;  178 200-206
    CrossrefPubMedGoogle Scholar
  • 96 Bearden C E, Hoffman K M, Cannon T D. The neuropsychology and neuroanatomy of bipolar affective disorder: a critical review.  Bipolar Disord. 2001;  3 (3) 106-150; discussion 151 - 153
    CrossrefPubMedGoogle Scholar
  • 97 Purcell R, Maruff P, Kyrios M, Pantelis C. Neuropsychological function in young patients with unipolar major depression.  Psychol Med. 1997;  27 (6) 1277-1285
    CrossrefPubMedGoogle Scholar
  • 98 Merriam E P, Thase M E, Haas G L, Keshavan M S, Sweeney J A. Prefrontal cortical dysfunction in depression determined by Wisconsin Card Sorting-Test performance.  Am J Psychiatry. 1999;  156 (5) 780-782
    PubMedGoogle Scholar
  • 99 Porter R J, Gallagher P, Thompson J M, Young A H. Neurocognitive impairment in drug-free patients with major depressive disorder.  Br J Psychiatry. 2003;  182 (3) 214-220
    CrossrefPubMedGoogle Scholar
  • 100 Landro N I, Stiles T C, Sletvold H. Neuropsychological function in nonpsychotic unipolar major depression.  Neuropsychiatry Neuropsychol Behav Neurol. 2001;  14 (4) 233-240
    PubMedGoogle Scholar
  • 101 Videbech P. PET measurements of brain glucose metabolism and blood flow in major depressive disorder: a critical review.  Acta Psychiatr Scand. 2000;  101 (1) 11-20
    PubMedGoogle Scholar
  • 102 Trichard C, Martinot J L, Alagille M, Masure M C, Hardy P, Ginestet D, Feline A. Time course of prefrontal lobe dysfunction in severely depressed in patients: a longitudinal neuropsychological study.  Psychol Med. 1995;  25 (1) 79-85
    PubMedGoogle Scholar
  • 103 Kaiser S, Unger J, Kiefer M, Markela J, Mundt C, Weisbrod M. Executive Control Deficit in Depression: Event-Related Potentials in a Go/Nogo Task.  Psychiatry Res Neuroimaging. 2003;  122 169-184
    CrossrefPubMedGoogle Scholar
  • 104 Degl'Innocenti A, Agren H, Backman L. Executive deficits in major depression.  Acta Psychiatr Scand. 1998;  97 (3) 182-188
    PubMedGoogle Scholar
  • 105 Austin M P, Mitchell P, Wilhelm K, Parker G, Hickie I, Brodaty H, Chan J, Eyers K, Milic M, Hadzi-Pavlovic D. Cognitive function in depression: a distinct pattern of frontal impairment in melancholia?.  Psychol Med. 1999;  29 (1) 73-85
    CrossrefPubMedGoogle Scholar
  • 106 Dolan R J, Bench C J, Liddle P F, Friston K J, Frith C D, Grasby P M, Frackowiak R S. Dorsolateral prefrontal cortex dysfunction in the major psychoses; symptom or disease specificity?.  J Neurol Neurosurg Psychiatry. 1993;  56 (12) 1290-1294
    PubMedGoogle Scholar
  • 107 Dolan R J, Bench C J, Brown R G, Scott L C, Frackowiak R S. Neuropsychological dysfunction in depression: the relationship to regional cerebral blood flow.  Psychol Med. 1994;  24 (4) 849-857
    PubMedGoogle Scholar
  • 108 Borkowska A, Rybakowski J K. Neuropsychological frontal lobe tests indicate that bipolar depressed patients are more impaired than unipolar.  Bipolar Disord. 2001;  3 (2) 88-94
    CrossrefPubMedGoogle Scholar
  • 109 Neu P, Kiesslinger U, Schlattmann P, Reischies F M. Time-related cognitive deficiency in four different types of depression.  Psychiatry Res. 2001;  103 (2 - 3) 237-247
    CrossrefPubMedGoogle Scholar
  • 110 Lockwood K A, Alexopoulos G S, Gorp W G van. Executive dysfunction in geriatric depression.  Am J Psychiatry. 2002;  159 (7) 1119-1126
    CrossrefPubMedGoogle Scholar
  • 111 Quraishi S, Frangou S. Neuropsychology of bipolar disorder: a review.  J Affect Disord. 2002;  72 (3) 209-226
    CrossrefPubMedGoogle Scholar
  • 112 Morice R. Cognitive inflexibility and pre-frontal dysfunction in schizophrenia and mania.  Br J Psychiatry. 1990;  157 50-54
    PubMedGoogle Scholar
  • 113 Clark L, Iversen S D, Goodwin G M. A neuropsychological investigation of prefrontal cortex involvement in acute mania.  Am J Psychiatry. 2001;  158 (10) 1605-1611
    CrossrefPubMedGoogle Scholar
  • 114 Rubinsztein J S, Fletcher P C, Rogers R D, Ho L W, Aigbirhio F I, Paykel E S, Robbins T W, Sahakian B J. Decision-making in mania: a PET study.  Brain. 2001;  124 (Pt 12) 2550-2563
    CrossrefPubMedGoogle Scholar
  • 115 Paradiso S, Lamberty G J, Garvey M J, Robinson R G. Cognitive impairment in the euthymic phase of chronic unipolar depression.  J Nerv Ment Dis. 1997;  185 (12) 748-754
    CrossrefPubMedGoogle Scholar
  • 116 Clark L, Iversen S D, Goodwin G M. Sustained attention deficit in bipolar disorder.  Br J Psychiatry. 2002;  180 313-319
    CrossrefPubMedGoogle Scholar
  • 117 Zubieta J K, Huguelet P, O'Neil R L, Giordani B J. Cognitive function in euthymic bipolar I disorder.  Psychiatry Res. 2001;  102 (1) 9-20
    CrossrefPubMedGoogle Scholar
  • 118 Martinez-Aran A, Penades R, Vieta E, Colom F, Reinares M, Benabarre A, Salamero M, Gasto C. Executive function in patients with remitted bipolar disorder and schizophrenia and its relationship with functional outcome.  Psychother Psychosom. 2002;  71 (1) 39-46
    PubMedGoogle Scholar
  • 119 Alexopoulos G S, Meyers B S, Young R C, Kalayam B, Kakuma T, Gabrielle M, Sirey J A, Hull J. Executive dysfunction and long-term outcomes of geriatric depression.  Arch Gen Psychiatry. 2000;  57 (3) 285-290
    PubMedGoogle Scholar
  • 120 Dunkin J J, Leuchter A F, Cook I A, Kasl-Godley J E, Abrams M, Rosenberg-Thompson S. Executive dysfunction predicts nonresponse to fluoxetine in major depression.  J Affect Disord. 2000;  60 (1) 13-23
    CrossrefPubMedGoogle Scholar
  • 121 Kaiser S, Mundt C, Weisbrod M. Störung der exekutiven Kontrollfunktionen bei depressiven Patienten - Implikationen für die Psychotherapie. In: Schiepek G (Hrsg). Neurobiologie der Psychotherapie. Stuttgart: Schattauer 2003
    Google Scholar
  • 122 Soares J C, Mann J J. The anatomy of mood disorders - review of structural neuroimaging studies.  Biol Psychiatry. 1997;  41 (1) 86-106
    CrossrefPubMedGoogle Scholar
  • 123 Ebert D, Lammers C-H. Das zentrale dopaminerge System und die Depression.  Nervenarzt. 1999;  68 545-555
    PubMedGoogle Scholar
  • 124 Modell J G, Mountz J M, Curtis G C, Greden J F. Neurophysiologic dysfunction in basal ganglia/limbic striatal and thalamocortical circuits as a pathogenetic mechanism of obsessive-compulsive disorder.  J Neuropsychiatry Clin Neurosci. 1989;  1 (1) 27-36
    PubMedGoogle Scholar
  • 125 Saxena S, Brody A L, Schwartz J M, Baxter L R. Neuroimaging and frontal-subcortical circuitry in obsessive-compulsive disorder.  Br J Psychiatry Suppl. 1998;  (35) 26-37
    PubMedGoogle Scholar
  • 126 Anderson K E, Savage C R. Cognitive and neurobiological findings in obsessive-compulsive disorder.  Psychiatr Clin North Am. 2004;  27 (1) 37-47, viii
    CrossrefPubMedGoogle Scholar
  • 127 Kuelz A K, Hohagen F, Voderholzer U. Neuropsychological performance in obsessive-compulsive disorder: a critical review.  Biol Psychol. 2004;  65 (3) 185-236
    Google Scholar
  • 128 Evans D W, Lewis M D, Iobst E. The role of the orbitofrontal cortex in normally developing compulsive-like behaviors and obsessive-compulsive disorder.  Brain Cogn. 2004;  55 (1) 220-234
    PubMedGoogle Scholar
  • 129 Basso M R, Bornstein R A, Carona F, Morton R. Depression accounts for executive function deficits in obsessive-compulsive disorder.  Neuropsychiatry Neuropsychol Behav Neurol. 2001;  14 (4) 241-245
    PubMedGoogle Scholar
  • 130 Mataix-Cols D, Alonso P, Pifarre J, Menchon J M, Vallejo J. Neuropsychological performance in medicated vs. unmedicated patients with obsessive-compulsive disorder.  Psychiatry Res. 2002;  109 (3) 255-264
    CrossrefPubMedGoogle Scholar
  • 131 Nielen M M, Den Boer J A. Neuropsychological performance of OCD patients before and after treatment with fluoxetine: evidence for persistent cognitive deficits.  Psychol Med. 2003;  33 (5) 917-925
    CrossrefPubMedGoogle Scholar
  • 132 Kunert H J, Druecke H W, Sass H, Herpertz S C. Frontal lobe dysfunctions in borderline personality disorder? Neuropsychological findings.  J Personal Disord. 2003;  17 (6) 497-509
    PubMedGoogle Scholar
  • 133 Monarch E S, Saykin A J, Flashman L A. Neuropsychological impairment in borderline personality disorder.  Psychiatr Clin North Am. 2004;  27 (1) 67-82, viii-ix
    CrossrefPubMedGoogle Scholar
  • 134 Bazanis E, Rogers R D, Dowson J H, Taylor P, Meux C, Staley C, Nevinson-Andrews D, Taylor C, Robbins T W, Sahakian B J. Neurocognitive deficits in decision-making and planning of patients with DSM-III-R borderline personality disorder.  Psychol Med. 2002;  32 (8) 1395-1405
    CrossrefPubMedGoogle Scholar
  • 135 Rentrop M, Unger J, Weisbrod M, Renneberg B. Response Inhibition in Borderline Personality Disorder: Performance in a Go/Nogo task. Eingereicht
    Google Scholar
  • 136 Soloff P H, Meltzer C C, Becker C, Greer P J, Kelly T M, Constantine D. Impulsivity and prefrontal hypometabolism in borderline personality disorder.  Psychiatry Res. 2003;  123 (3) 153-163
    PubMedGoogle Scholar
  • 137 Brower M C, Price B H. Neuropsychiatry of frontal lobe dysfunction in violent and criminal behaviour: a critical review.  J Neurol Neurosurg Psychiatry. 2001;  71 (6) 720-726
    CrossrefPubMedGoogle Scholar
  • 138 Dolan M, Park I. The neuropsychology of antisocial personality disorder.  Psychol Med. 2002;  32 (3) 417-427
    CrossrefPubMedGoogle Scholar
  • 139 Vollm B, Richardson P, Stirling J, Elliott R, Dolan M, Chaudhry I, Del Ben C, McKie S, Anderson I, Deakin B. Neurobiological substrates of antisocial and borderline personality disorder: preliminary results of a functional fMRI study.  Crim Behav Ment Health. 2004;  14 (1) 39-54
    PubMedGoogle Scholar
  • 140 Coull J T. Neural correlates of attention and arousal: insights from electrophysiology, functional neuroimaging and psychopharmacology.  Prog Neurobiol. 1998;  55 (4) 343-361
    CrossrefPubMedGoogle Scholar
  • 141 Robbins T W. Chemical neuromodulation of frontal-executive functions in humans and other animals.  Exp Brain Res. 2000;  133 (1) 130-138
    CrossrefPubMedGoogle Scholar
  • 142 Nieoullon A. Dopamine and the regulation of cognition and attention.  Prog Neurobiol. 2002;  67 (1) 53-83
    CrossrefPubMedGoogle Scholar
  • 143 Honey G D, Bullmore E T, Soni W, Varatheesan M, Williams S C, Sharma T. Differences in frontal cortical activation by a working memory task after substitution of risperidone for typical antipsychotic drugs in patients with schizophrenia.  Proc Natl Acad Sci U S A. 1999;  96 (23) 13 432-13 437
    PubMedGoogle Scholar
  • 144 Marin R S. Apathy: Concept, Syndrome, Neural Mechanisms, and Treatment.  Semin Clin Neuropsychiatry. 1996;  1 (4) 304-314
    PubMedGoogle Scholar
  • 145 Meltzer H Y, Park S, Kessler R. Cognition, schizophrenia, and the atypical antipsychotic drugs.  Proc Natl Acad Sci U S A. 1999;  96 (24) 13 591-13 593
    PubMedGoogle Scholar
  • 146 Friedman J I, Temporini H, Davis K L. Pharmacologic strategies for augmenting cognitive performance in schizophrenia.  Biol Psychiatry. 1999;  45 (1) 1-16
    CrossrefPubMedGoogle Scholar
  • 147 Lidow M S, Goldman-Rakic P S, Gallager D W, Rakic P. Distribution of dopaminergic receptors in the primate cerebral cortex: quantitative autoradiographic analysis using [3H]raclopride, [3H]spiperone and [3H]SCH23390.  Neuroscience. 1991;  40 (3) 657-671
    CrossrefPubMedGoogle Scholar
  • 148 Muller U, Cramon D Y von, Pollmann S. D1- versus D2-receptor modulation of visuospatial working memory in humans.  J Neurosci. 1998;  18 (7) 2720-2728
    PubMedGoogle Scholar
  • 149 Roesch-Ely D, Scheffel H, Weiland S, Schwaninger M, Hundemer H P, Kolter T, Witte S, Weisbrod M. Dopaminergic Modulation of PFC functions in schizophrenic patients. Eingereicht
    Google Scholar
  • 150 Kimberg D Y, D'Esposito M, Farah M J. Effects of bromocriptine on human subjects depend on working memory capacity.  Neuroreport. 1997;  8 (16) 3581-3585
    PubMedGoogle Scholar
  • 151 Harvey P D, Keefe R S. Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment.  Am J Psychiatry. 2001;  158 (2) 176-184
    Google Scholar
  • 152 Richelson E. Pharmacology of antidepressants - characteristics of the ideal drug.  Mayo Clin Proc. 1994;  69 (11) 1069-1681
    CrossrefPubMedGoogle Scholar
  • 153 Arnsten A F, Steere J C, Hunt R D. The contribution of α2-noradrenergic mechanisms of prefrontal cortical cognitive function. Potential significance for attention-deficit hyperactivity disorder.  Arch Gen Psychiatry. 1996;  53 (5) 448-455
    CrossrefPubMedGoogle Scholar
  • 154 Moffoot A, O'Carroll R E, Murray C, Dougall N, Ebmeier K, Goodwin G M. Clonidine infusion increases uptake of 99mTc-Exametazime in anterior cingulate cortex in Korsakoff's psychosis.  Psychol Med. 1994;  24 (1) 53-61
    PubMedGoogle Scholar
  • 155 Fields R B, Kammen D P van, Peters J L, Rosen J, Kammen W B van, Nugent A, Stipetic M, Linnoila M. Clonidine improves memory function in schizophrenia independently from change in psychosis. Preliminary findings.  Schizophr Res. 1988;  1 (6) 417-423
    CrossrefPubMedGoogle Scholar
  • 156 Ferguson J M, Wesnes K A, Schwartz G E. Reboxetine versus paroxetine versus placebo: effects on cognitive functioning in depressed patients.  Int Clin Psychopharmacol. 2003;  18 (1) 9-14
    PubMedGoogle Scholar
  • 157 Meltzer H Y. The role of serotonin in antipsychotic drug action.  Neuropsychopharmacology. 1999;  21 (2 Suppl) 106S-115S
    PubMedGoogle Scholar
  • 158 Rogers R D, Blackshaw A J, Middleton H C, Matthews K, Hawtin K, Crowley C, Hopwood A, Wallace C, Deakin J F, Sahakian B J, Robbins T W. Tryptophan depletion impairs stimulus-reward learning while methylphenidate disrupts attentional control in healthy young adults: implications for the monoaminergic basis of impulsive behaviour.  Psychopharmacology (Berl). 1999;  146 (4) 482-491
    PubMedGoogle Scholar
  • 159 Fava M. Psychopharmacologic treatment of pathologic aggression.  Psychiatr Clin North Am. 1997;  20 (2) 427-451
    CrossrefPubMedGoogle Scholar
  • 160 Hollander E, Rosen J. Impulsivity.  J Psychopharmacol. 2000;  14 (2 Suppl 1) S39-44
    PubMedGoogle Scholar
  • 161 Kopelman M D. The cholinergic neurotransmitter system in human memory and dementia: a review.  Q J Exp Psychol A. 1986;  38 (4) 535-573
    PubMedGoogle Scholar
  • 162 Everitt B, Robbins T W. Central cholinergic systems and cognition.  Annu Rev Psychol. 1996;  48 649-684
    PubMedGoogle Scholar
  • 163 Cummings J L. Use of cholinesterase inhibitors in clinical practice: evidence-based recommendations.  Am J Geriatr Psychiatry. 2003;  11 (2) 131-145
    PubMedGoogle Scholar
  • 164 Amenta F, Di Tullio M A, Tomassoni D. The cholinergic approach for the treatment of vascular dementia: evidence from pre-clinical and clinical studies.  Clin Exp Hypertens. 2002;  24 (7 - 8) 697-713
    CrossrefPubMedGoogle Scholar
  • 165 Griffin S L, Reekum R van, Masanic C. A review of cholinergic agents in the treatment of neurobehavioral deficits following traumatic brain injury.  J Neuropsychiatry Clin Neurosci. 2003;  15 (1) 17-26
    PubMedGoogle Scholar
  • 166 Mateer C A. Executive function disorders: rehabilitation challenges and strategies.  Semin Clin Neuropsychiatry. 1999;  4 (1) 50-59
    PubMedGoogle Scholar
  • 167 Gauggel S. Neuropsychologische Therapie der Frontalhirnstörung: Therapieprogramme. In: Foerstl H (Hrsg). Der Frontallappen. Funktionen und Erkrankungen. Berlin: Springer 2002
    Google Scholar
  • 168 Backman L, Dixon R A. Psychological compensation: a theoretical framework.  Psychol Bull. 1992;  112 (2) 259-283
    CrossrefPubMedGoogle Scholar
  • 169 Campbell 3rd J J, Duffy J D, Salloway S P. Treatment strategies for patients with dysexecutive syndromes.  J Neuropsychiatry Clin Neurosci. 1994;  6 (4) 411-418
    PubMedGoogle Scholar
  • 170 Sohlberg M M, Mateer C. Cognitive Rehabilitation - An Integrative Neuropsychological Approach. New York: Guilford Press 2001
    Google Scholar
  • 171 Baddeley A D. Implicit memory and errorless learning: a link between cognitive theory and neuropsychological rehabilitation?. In: Squire LR, Buttes N (Hrsg). Neuropsychology of memory. 2. Aufl. New York: Guilford 1992: 309-314
    Google Scholar
  • 172 Kern R S, Liberman R P, Kopelowicz A, Mintz J, Green M F. Applications of errorless learning for improving work performance in persons with schizophrenia.  Am J Psychiatry. 2002;  159 (11) 1921-1926
    CrossrefPubMedGoogle Scholar
  • 173 Meichenbaum D. The potential contributions of cognitive behavior modification to the rehabilitation of individuals with traumatic brain injury.  Semin Speech Lang. 1993;  14 (1) 18-31
    PubMedGoogle Scholar
  • 174 Cicerone K D, Giacino J T. Remediation of executive function deficits.  Neurorehabilitation. 1992;  2 73-83
    PubMedGoogle Scholar
  • 175 Cramon D Y von, Matthes-von Cramon G. Back to work with a chronic dysexecutive syndrome? A case report.  Neuropsychol Rehab. 1994;  4 399-417
    PubMedGoogle Scholar
  • 176 Alderman N, Fry R K, Youngson H A. Improvement of self-monitoring skills, reduction of behavior disturbance and the dysexecutive syndrome: Comparison of response cost and a new programme of self-monitoring training.  Neuropsychol Rehab. 1995;  5 193-221
    PubMedGoogle Scholar
  • 177 Robertson I H, Murre J M. Rehabilitation of brain damage: brain plasticity and principles of guided recovery.  Psychol Bull. 1999;  125 (5) 544-575
    CrossrefPubMedGoogle Scholar
  • 178 Cramon D Y von, Matthes-von Cramon G, Mai N. Problem-solving deficits in brain-injured patients: A therapeutic approach.  Neuropsychological Rehabilitation. 1991;  1 45-64
    PubMedGoogle Scholar
  • 179 Sohlberg M M, Mateer C. Introduction to cognitive rehabilitation. New York: Guilford 1989
    Google Scholar
  • 180 Vauth R, Dietl M, Stieglitz R D, Olbrich H M. Kognitive Remediation - Eine neue Chance in der Rehabilitation schizophrener Störungen?.  Nervenarzt. 2000;  71 (1) 19-29
    CrossrefPubMedGoogle Scholar
  • 181 Bellack A S, Gold J M, Buchanan R W. Cognitive rehabilitation for schizophrenia: problems, prospects, and strategies.  Schizophr Bull. 1999;  25 (2) 257-274
    PubMedGoogle Scholar
  • 182 Delahunty A, Morice R. Rehabilitation of frontal/executive impairments in schizophrenia.  Aust N Z J Psychiatry. 1996;  30 (6) 760-767
    PubMedGoogle Scholar
  • 183 Wykes T, Reeder C, Corner J, Williams C, Everitt B. The effects of neurocognitive remediation on executive processing in patients with schizophrenia.  Schizophr Bull. 1999;  25 (2) 291-307
    PubMedGoogle Scholar
  • 184 Stablum F, Umilta C, Mogentale C, Carlan M, Guerrini C. Rehabilitation of executive deficits in closed head injury and anterior communicating artery aneurysm patients.  Psychological Research. 2000;  63 265-278
    PubMedGoogle Scholar
  • 185 Sohlberg M M, Raskin S. Principles of generalization applied to attention and memory interventions.  Journal of Head Trauma Rehabilitation. 1996;  11 (2) 65-78
    PubMedGoogle Scholar
  • 186 Grant D A, Berg E A. A behavioral analysis of the degree of reinforcement and ease of shifting to new responses in a Weigl-type card sorting problem.  J Exp Psychol. 1948;  38 404-411
    CrossrefPubMedGoogle Scholar
  • 187 Milner B. Effects of different brain lesions on card sorting.  Arch Neurol. 1963;  9 90-100
    CrossrefPubMedGoogle Scholar
  • 188 Jones-Gotman M, Milner B. Design fluency: the invention of nonsense drawings after focal cortical lesions.  Neuropsychologia. 1977;  15 633-674
    PubMedGoogle Scholar
  • 189 Shallice T. Specific impairments of planning.  Philos Trans R Soc Lond B Biol Sci. 1982;  298 199-209
    CrossrefPubMedGoogle Scholar
  • 190 Porteus S D. Porteus Maze Test: Fifty Years' Application. Palo Alto: Pacific Books 1965
    Google Scholar
  • 191 Oscar-Berman M, McNamara P, Freedman M. Delayed-response tasks: parallels between experimental ablation studies and findings in patients with frontal lesions. In: Benton A (Hrsg). Frontal Lobe Function and Dysfunction. New York: Oxford University Press 1991: 256-272
    Google Scholar
  • 192 Nystrom L E, Braver T S, Sabb F W, Delgado M R, Noll D C, Cohen J D. Working memory for letters, shapes, and locations: fMRI evidence against stimulus-based regional organization in human prefrontal cortex.  Neuroimage. 2000;  11 (5 Pt 1) 424-446
    CrossrefPubMedGoogle Scholar
  • 193 Rosvold H E, Mirsky A, Sarason I, Bransome Jr E D, Beck L H. A continuous performance test of brain damage.  Journal of Consulting Psychology. 1956;  20 343-350
    PubMedGoogle Scholar
  • 194 Stroop J. Studies of interference in serial verbal reactions.  J Exp Psychol. 1935;  18 643-662
    CrossrefPubMedGoogle Scholar
  • 195 Royall D R, Mahurin R K, Gray K F. Bedside assessment of executive cognitive impairment: the executive interview.  J Am Geriatr Soc. 1992;  40 (12) 1221-1226
    PubMedGoogle Scholar
  • 196 Royall D R, Cordes J A, Polk M. CLOX: an executive clock drawing task.  J Neurol Neurosurg Psychiatry. 1998;  64 (5) 588-594
    PubMedGoogle Scholar
  • 197 Grigsby J, Kaye K, Robbins L J. Reliabilities, norms and factor structure of the Behavioral Dyscontrol Scale.  Percept Mot Skills. 1992;  74 (3 Pt 1) 883-892
    PubMedGoogle Scholar
  • 198 Grace J, Stout J C, Malloy P F. Frontal Systems Behavior Scale: Professional manual. Lutz, Florida: Psychological Assessment Resources 2001
    Google Scholar
  • 199 Braswell D, Hartry A, Hoornbeek S, Johansen A, Johnson L, Schultz J, Sohlberg M M. Profile of the Executive Control System. Wake Forest: Lash & Associates 1993
    Google Scholar
  • 200 Gauggel S, Deckersbach T, Rolko C. Entwicklung und erste Evaluation einer Skala zur Beurteilung von Handlungs-, Planungs- und Problemlösestörungen.  Z Neuropsychol. 1998;  11 (3) 159-171
    PubMedGoogle Scholar
  • 201 Pechtold K, Jankowski P. Handeln lernen. München: Urban & Fischer 2000
    Google Scholar
  • 202 Wilson B A, Aldermann N, Burgess P W. et al .The Behavioural Assessment of the Dysexecutive Syndrome. Flempton: Thames Valley Test Company 1996
    Google Scholar
  • 203 Ettlin T M, Kischka U, Beckson M, Gaggiotti M, Rauchfleisch U, Benson D F. The Frontal Lobe Score: part I: construction of a mental status of frontal systems.  Clin Rehabil. 2000;  14 (3) 260-271
    CrossrefPubMedGoogle Scholar

PD Dr. med. Matthias Weisbrod

Psychiatrische Universitätsklinik

Voss-Strasse 4

69115 Heidelberg ·

Email: matthias_weisbrod@med.uni-heidelberg.de